Newstral
Article
Forbes on 2019-05-15 22:54
UroGen BrandVoice: Patients Left Behind: Transforming Therapy For Urologic Cancers
Related news
- Patients go nuts over new allergy therapyPalo Alto online
- ‘A true living drug’: FDA on cusp of approving gene therapy for blood cancersWashington Post
- Billings patients have acces to immunotherapy — a promising treatment for certain cancersbillingsgazette.com
- Billings patients have access to immunotherapy — a promising treatment for certain cancersbillingsgazette.com
- Cole Haan BrandVoice: Changemakers: Transforming A Passion Into A ProfessionForbes
- Medicare to cover breakthrough gene therapy for some cancersMerced Sun-Star
- Ketamine therapy for mental health a ‘Wild West’ for doctors, patientsocregister.com
- How Javier Milei’s “Shock Therapy” Is Transforming Argentina’s EconomyForbes
- IOrganoids created from patients' bladder cancers could guide treatmentinnovations-report.com
- Juno plunges after 3 patients die in trial of cancer therapyChicago Tribune
- Study of 25 stroke patients shows BrainQ’s wave therapy can reduce disabilitytimesofisrael.com